Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration
Clinical trial NCT05904691 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05904691
- Sponsor
- Ocugenix Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2026-11-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.